No Data
No Data
Xenon Pharmaceuticals Insiders Sell US$4.5m Of Stock, Possibly Signalling Caution
Over the past year, many Xenon Pharmaceuticals Inc. (NASDAQ:XENE) insiders sold a significant stake in the company which may have piqued investors' interest.
Xenon Pharmaceuticals Price Target Maintained With a $62.00/Share by Needham
Xenon Pharmaceuticals Price Target Maintained With a $62.00/Share by Needham
Xenon Pharmaceuticals Is Maintained at Buy by Citigroup
Xenon Pharmaceuticals Is Maintained at Buy by Citigroup
Express News | Citigroup Maintains Buy on Xenon Pharmaceuticals, Lowers Price Target to $60
Xenon Pharmaceuticals: A Strong Buy on Clinical Progress and Robust Financials
Xenon Pharmaceuticals Inc (XENE) Reports Increased Losses in Q1 2024, Despite Advancements in ...